Companies / Rapid Micro Biosystems, Inc. / Activity
Activity — Rapid Micro Biosystems, Inc.
53 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Longitude Capital Partners II, LLC 10% owner | Sell | Class A Common Stock | $209.0K | -46K -30.67% | 104,000 0.21% of shares | medium |
| Feb 4, 2026 | Longitude Capital Partners II, LLC 10% owner | Sell | Class A Common Stock | $190.1K | -49K -100.00% | 0 0.00% of shares | medium |
| Feb 19, 2026 | Spignesi Robert G. Jr. CEO | Sell | Class A Common Stock | $148.9K | -38K -3.13% | 1,187,770 2.37% of shares | medium |
| Feb 2, 2026 | Longitude Capital Partners II, LLC 10% owner | Sell | Class A Common Stock | $116.8K | -28K -26.44% | 76,500 0.15% of shares | medium |
| Feb 3, 2026 | Longitude Capital Partners II, LLC 10% owner | Sell | Class A Common Stock | $116.6K | -28K -35.95% | 49,000 0.10% of shares | medium |
| Mar 10, 2026 | Spignesi Robert G. Jr. CEO | Sell | Class A Common Stock | $73.7K | -18K -1.51% | 1,169,848 2.33% of shares | low |
| Feb 20, 2026 | Wirtjes Sean M Executive | Sell | Class A Common Stock | $67.7K | -17K -2.97% | 563,674 1.12% of shares | low |
| Feb 9, 2026 | Spignesi Robert G. Jr. CEO | Sell | Class A Common Stock | $48.6K | -13K -1.32% | 962,097 1.92% of shares | low |
| Mar 11, 2026 | Wilson John J. Addington Executive | Sell | Class A Common Stock | $41.5K | -10K -2.94% | 316,762 0.63% of shares | low |
| Mar 11, 2026 | Wirtjes Sean M Executive | Sell | Class A Common Stock | $32.3K | -7K -1.33% | 556,194 1.11% of shares | low |
| Jan 23, 2026 | Longitude Capital Partners II, LLC 10% owner | Exercise | Class A Common Stock | $31.5K | +629K +18.46% | 4,036,984 8.05% of shares | low |
| Jan 23, 2026 | Longitude Capital Partners II, LLC 10% owner | Sell | Class A Common Stock | $31.5K | -8K -0.19% | 4,029,245 8.03% of shares | low |
| May 29, 2026 | Lowenstein Inese Director | Grant | Class A Common Stock | $25.0K | +13K +22.08% | 70,687 0.14% of shares | low |
| May 29, 2026 | Spignesi Robert G. Jr. CEO | Grant | Class A Common Stock | $25.0K | +13K +1.09% | 1,190,571 2.37% of shares | low |
| May 29, 2026 | Pei Melinda Litherland Director | Grant | Class A Common Stock | $25.0K | +13K +14.55% | 100,687 0.20% of shares | low |
| May 29, 2026 | Malloy Kirk Director | Grant | Class A Common Stock | $25.0K | +13K +26.70% | 60,687 0.12% of shares | low |
| May 29, 2026 | Wirtjes Sean M Executive | Grant | Class A Common Stock | $25.0K | +13K +2.30% | 568,981 1.13% of shares | low |
| Feb 9, 2026 | Wirtjes Sean M Executive | Sell | Class A Common Stock | $22.8K | -6K -1.23% | 483,928 0.96% of shares | low |
| Feb 20, 2026 | Wilson John J. Addington Executive | Sell | Class A Common Stock | $21.2K | -5K -1.63% | 326,365 0.65% of shares | low |
| Feb 9, 2026 | Wilson John J. Addington Executive | Sell | Class A Common Stock | $17.4K | -5K -1.76% | 257,768 0.51% of shares | low |
| Feb 27, 2026 | Ricciardi Natale S Director | Exercise | Class A Common Stock | $632 | +842 +2.94% | 29,442 0.06% of shares | low |
| May 21, 2026 | Bika Dafni Director | Grant | Class A Common Stock | $0 | +19K | 19,300 0.04% of shares | low |
| May 21, 2026 | Lowenstein Inese Director | Grant | Class A Common Stock | $0 | +19K +50.00% | 57,900 0.12% of shares | low |
| May 21, 2026 | Pei Melinda Litherland Director | Grant | Class A Common Stock | $0 | +19K +28.13% | 87,900 0.18% of shares | low |
| May 21, 2026 | Kollender Richard S Director | Grant | Class A Common Stock | $0 | +19K +17.38% | 130,318 0.26% of shares | low |
| May 21, 2026 | Malloy Kirk Director | Grant | Class A Common Stock | $0 | +19K +67.48% | 47,900 0.10% of shares | low |
| Feb 11, 2026 | Wilson John J. Addington Executive | Grant | Class A Common Stock | $0 | +74K +28.71% | 331,768 0.66% of shares | low |
| Feb 11, 2026 | Wirtjes Sean M Executive | Grant | Class A Common Stock | $0 | +97K +20.04% | 580,928 1.16% of shares | low |
| Feb 11, 2026 | Spignesi Robert G. Jr. CEO | Grant | Class A Common Stock | $0 | +264K +27.44% | 1,226,097 2.44% of shares | low |
| May 29, 2026 | Lowenstein Inese Director | Grant | Series B Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Lowenstein Inese Director | Grant | Series A Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Spignesi Robert G. Jr. CEO | Grant | Series B Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Spignesi Robert G. Jr. CEO | Grant | Series A Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Pei Melinda Litherland Director | Grant | Series B Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Pei Melinda Litherland Director | Grant | Series A Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 21, 2026 | Bika Dafni Director | Grant | Stock Option (Right to Buy) | — | +39K | 38,700 0.08% of shares | low |
| May 21, 2026 | Lowenstein Inese Director | Grant | Stock Option (Right to Buy) | — | +39K | 38,700 0.08% of shares | low |
| May 21, 2026 | Pei Melinda Litherland Director | Grant | Stock Option (Right to Buy) | — | +39K | 38,700 0.08% of shares | low |
| May 21, 2026 | Kollender Richard S Director | Grant | Stock Option (Right to Buy) | — | +39K | 38,700 0.08% of shares | low |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Buy | Series B Warrant (right to buy) | — | +1.5M | 1,463,000 2.92% of shares | low |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Buy | Series A Warrant (right to buy) | — | +1.5M | 1,463,000 2.92% of shares | low |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC 10% owner | Buy | Pre-Funded Warrant (right to buy) | — | +1.5M | 1,463,000 2.92% of shares | low |
| May 29, 2026 | Malloy Kirk Director | Grant | Series B Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Malloy Kirk Director | Grant | Series A Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 21, 2026 | Malloy Kirk Director | Grant | Stock Option (Right to Buy) | — | +39K | 38,700 0.08% of shares | low |
| May 29, 2026 | Wirtjes Sean M Executive | Grant | Series B Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| May 29, 2026 | Wirtjes Sean M Executive | Grant | Series A Warrant (right to buy) | — | +13K | 12,787 0.03% of shares | low |
| Jan 23, 2026 | Longitude Capital Partners II, LLC 10% owner | Exercise | Class A Common Stock | — | -129K -100.00% | 0 0.00% of shares | low |
| Jan 23, 2026 | Longitude Capital Partners II, LLC 10% owner | Exercise | Class A Common Stock | — | -500K -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Ricciardi Natale S Director | Exercise | Stock Option (Right to Buy) | — | -842 -100.00% | 0 0.00% of shares | low |